ONCYOncolytics Biotech Inc.

ONCY Stock Price, Valuation & Chart | Oncolytics Biotech Inc.

Compare

$0.880+0.04 (+4.76%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ONCY intrinsic value ONCY calculated fair value vs price

Overview Financials Dividends Ratios

ONCY Historical price chart

ONCY Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization88.32M

PE Ratio-2.59

EPS-0.34

Trading Volume1.58M

Today's High/Low0.91/0.84

Dividend Yield0.00

52 Week High/Low1.51/0.73

Shares Outstanding100.36M

ONCY Financial Statement

ONCY Analyst ratings

ONCY Analysis & performance metrics

ONCY Company profile

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its…

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA…

ONCY Management team

Name

Position

Thomas C. Heineman M.D., Ph.D.

Chief Medical Officer

Jared Kelly J.D., L.L.M.CEO

Chief Executive Officer & Director

Andrew P. Aromando

Chief Business Officer

Allison Hagerman P.Eng., P.M.P.

Vice President of Product Development

Jon PattonCTO

Director of Investor Relations & Communication

Kirk J. Look C.A., CPACFO

Chief Financial Officer

Amy Goodowitz Levin B.S.N., R.N.

Vice President of Clinical Operations

John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.

Consultant

Name

Position

Thomas C. Heineman M.D., Ph.D.

Chief Medical Officer

Jared Kelly J.D., L.L.M.CEO

Chief Executive Officer & Director

Andrew P. Aromando

Chief Business Officer

Allison Hagerman P.Eng., P.M.P.

Vice President of Product Development

Jon PattonCTO

Director of Investor Relations & Communication

Kirk J. Look C.A., CPACFO

Chief Financial Officer

Amy Goodowitz Levin B.S.N., R.N.

Vice President of Clinical Operations

John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.

Consultant

Management Team

Thomas C. Heineman M.D., Ph.D.

Chief Medical Officer

Jared Kelly J.D., L.L.M.CEO

Chief Executive Officer & Director

Andrew P. Aromando

Chief Business Officer

Allison Hagerman P.Eng., P.M.P.

Vice President of Product Development

Jon PattonCTO

Director of Investor Relations & Communication

Kirk J. Look C.A., CPACFO

Chief Financial Officer

Amy Goodowitz Levin B.S.N., R.N.

Vice President of Clinical Operations

John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.

Consultant

Management

Thomas C. Heineman M.D., Ph.D.

Chief Medical Officer

Jared Kelly J.D., L.L.M.CEO

Chief Executive Officer & Director

Andrew P. Aromando

Chief Business Officer

Allison Hagerman P.Eng., P.M.P.

Vice President of Product Development

Jon PattonCTO

Director of Investor Relations & Communication

Kirk J. Look C.A., CPACFO

Chief Financial Officer

Amy Goodowitz Levin B.S.N., R.N.

Vice President of Clinical Operations

John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.

Consultant

Total 8 executives

ONCY Frequently asked questions

What is Oncolytics Biotech Inc. (ONCY) Stock Price?

Current stock price of Oncolytics Biotech Inc. (ONCY) stock is $0.880. The stock price is +4.76% higher in the session. The intraday range can be seen from this page. Volume of Oncolytics Biotech Inc. (ONCY) stock is 1.58M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Oncolytics Biotech Inc. (ONCY) stock price going up or down today?

The stock price of Oncolytics Biotech Inc. (ONCY) can change with earnings, company news, and overall market sentiment. Oncolytics Biotech Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Oncolytics Biotech Inc. stock expensive at its current price?

Whether Oncolytics Biotech Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ONCY on this page is -2.59. EPS on this page is -0.34. Compare those figures with peers and growth expectations before deciding if the current Oncolytics Biotech Inc. price is justified.

How has the stock price of Oncolytics Biotech Inc. (ONCY) performed historically?

Historical performance for Oncolytics Biotech Inc. (ONCY) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ONCY reacted to past earnings and market events.

Should I buy Oncolytics Biotech Inc. (ONCY) stock, at this price?

Buying Oncolytics Biotech Inc. (ONCY) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.